SCHEMBL13640225

SCHEMBL13640225

CC/C=C/COc1ccc(C)cc1C(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
MAPT P10636 3/20 0.36
POLB P06746 3/20 0.36
LMNA P02545 3/20 0.36
TRPA1 O75762 1/20 0.36
CHRM1 P11229 1/20 0.36
SLC6A2 P23975 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
NPBWR1 P48145 1/20 0.36
MCHR1 Q99705 1/20 0.36
KDM4E B2RXH2 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
THRB P10828 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9945918 0.81 L3MBTL1 (0.46) ALDH1A1MAPTPOLBLMNATRPA1
SCHEMBL13623380 0.79 KMT2A (0.43) ALDH1A1LMNASLC6A2SMN1; SMN2L3MBTL1
SCHEMBL20150593 0.78 MRGPRX4 (0.42) ALDH1A1MAPTPOLBSLC6A2KDM4E
SCHEMBL9945954 0.77 ALDH1A1 (0.48) ALDH1A1MAPTPOLBLMNATRPA1
SCHEMBL12952630 0.74 ALDH1A1 (0.50) ALDH1A1MAPTPOLBSMN1; SMN2NPBWR1
SCHEMBL24133302 0.73 LMNA (0.40) ALDH1A1MAPTPOLBLMNATRPA1
SCHEMBL25195625 0.73 ALDH1A1 (0.51) ALDH1A1MAPTPOLBSMN1; SMN2NPBWR1
SCHEMBL18959732 0.72 ALDH1A1 (0.47) ALDH1A1LMNATRPA1CHRM1SLC6A2
SCHEMBL18959733 0.72 ALDH1A1 (0.45) ALDH1A1MAPTPOLBSMN1; SMN2NPBWR1
SCHEMBL11010571 0.72 LMNA (0.48) ALDH1A1POLBLMNATRPA1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics SIGNATURE THERAPEUTICS, INC. 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283335-A1 Analogs of Propofol, Preparation Thereof and Use as Anesthetics GABRP, CYP4F11, CYP2F1 ALDH1A1 328/4885MAPT 3638/4885POLB 3108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.